Table 5.

Rates of adverse outcomes

	Control group	PCT/Pyuria group	Odds ratio	95% CI	P value a
All patients (intention-to-treat)	(n = 64)	(n = 61)
Recurrence	14/63 (22%)	15/59 (25%)	1.19	0.52–2.75	0.68
Rehospitalization	17/63 (27%)	15/59 (25%)	0.92	0.41–2.07	0.85
Death	4/63 (6%)	1/59 (2%)	0.25	0.03–2.30	0.22
Per-protocol population	(n = 52)	(n = 44)
Recurrence	11/52 (21%)	14/44 (32%)	1.74	0.69–4.36	0.24
Rehospitalization	13/52 (35%)	13/44 (41%)	1.26	0.51–3.10	0.62
Death	1/52 (2%)	0
Inpatients	(n = 45)	(n = 45)
Recurrence	11 (25%)	13 (30%)	1.26	0.49–3.22	0.63
Rehospitalization	15 (34%)	13 (30%)	0.81	0.28–0.96	0.65
Uncomplicated simple UTI	(n = 6)	(n = 2)
Recurrence	1/6 (17%)	1/2 (50%)	5.00	0.15–166.59	0.37
Rehospitalization	1/6 (17%)	1/2 (50%)	5.00	0.15–166.59	0.37
Complicated simple UTI	(n = 12)	(n = 16)
Recurrence	3/11 (27%)	6/16 (38%)	1.60	0.30–8.49	0.58
Rehospitalization	2/11 (18%)	6/16 (38%)	2.70	0.43–16.94	0.29
Uncomplicated febrile UTI/pyelonephritis	(n = 8)	(n = 9)
Recurrence	1/8 (13%)	2/8 (25%)	2.33	0.17–32.58	0.53
Rehospitalization	2/8 (25%)	1/8 (13%)	0.43	0.03–5.98	0.53
Complicated febrile UTI/pyelonephritis	(n = 34)	(n = 33)
Recurrence	8/34 (24%)	6/32 (19%)	0.75	0.23–2.47	0.64
Rehospitalization	11/34 (32%)	7/32 (22%)	0.59	0.19–1.77	0.34

^aLogistic regression analysis.